These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 24679476)

  • 1. Comparing parasitological vs serological determination of Schistosoma haematobium infection prevalence in preschool and primary school-aged children: implications for control programmes.
    Wami WM; Nausch N; Bauer K; Midzi N; Gwisai R; Simmonds P; Mduluza T; Woolhouse M; Mutapi F
    Parasitology; 2014 Dec; 141(14):1962-70. PubMed ID: 24679476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of praziquantel on Schistosoma haematobium and re-infection rates among school-going children in the Ndumo area of uMkhanyakude district, KwaZulu-Natal, South Africa.
    Kabuyaya M; Chimbari MJ; Manyangadze T; Mukaratirwa S
    Infect Dis Poverty; 2017 Apr; 6(1):83. PubMed ID: 28385154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Single Dose Praziquantel Treatment on Schistosoma haematobium Infection among School Children in an Endemic Nigerian Community.
    Adewale B; Mafe MA; Sulyman MA; Idowu ET; Ajayi MB; Akande DO; Mckerrow JH; Balogun EO
    Korean J Parasitol; 2018 Dec; 56(6):577-581. PubMed ID: 30630278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and side effects of praziquantel treatment against Schistosoma haematobium infection among primary school children in Zimbabwe.
    Midzi N; Sangweme D; Zinyowera S; Mapingure MP; Brouwer KC; Kumar N; Mutapi F; Woelk G; Mduluza T
    Trans R Soc Trop Med Hyg; 2008 Aug; 102(8):759-66. PubMed ID: 18486169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of two closely spaced doses of praziquantel against Schistosoma haematobium and S. mansoni and re-infection patterns in school-aged children in Niger.
    Garba A; Lamine MS; Barkiré N; Djibo A; Sofo B; Gouvras AN; Labbo R; Sebangou H; Webster JP; Fenwick A; Utzinger J
    Acta Trop; 2013 Nov; 128(2):334-44. PubMed ID: 22940014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective, observational study to assess the performance of CAA measurement as a diagnostic tool for the detection of Schistosoma haematobium infections in pregnant women and their child in Lambaréné, Gabon: study protocol of the freeBILy clinical trial in Gabon.
    Honkpehedji YJ; Adegnika AA; Dejon-Agobe JC; Zinsou JF; Mba RB; Gerstenberg J; Rakotozandrindrainy R; Rakotoarivelo RA; Rasamoelina T; Sicuri E; Schwarz NG; Corstjens PLAM; Hoekstra PT; van Dam GJ; Kreidenweiss A;
    BMC Infect Dis; 2020 Sep; 20(1):718. PubMed ID: 32993559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urogenital schistosomiasis in Cabo Delgado, northern Mozambique: baseline findings from the SCORE study.
    Phillips AE; Gazzinelli-Guimarães PH; Aurelio HO; Dhanani N; Ferro J; Nala R; Deol A; Fenwick A
    Parasit Vectors; 2018 Jan; 11(1):30. PubMed ID: 29316983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrasonographic evaluation of urinary tract morbidity in school-aged and preschool-aged children infected with Schistosoma haematobium and its evolution after praziquantel treatment: A randomized controlled trial.
    Barda B; Coulibaly JT; Hatz C; Keiser J
    PLoS Negl Trop Dis; 2017 Feb; 11(2):e0005400. PubMed ID: 28222149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exposure, infection and immune responses to Schistosoma haematobium in young children.
    Woolhouse ME; Mutapi F; Ndhlovu PD; Chandiwana SK; Hagan P
    Parasitology; 2000 Jan; 120 ( Pt 1)():37-44. PubMed ID: 10726264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Schistosoma haematobium treatment in 1-5 year old children: safety and efficacy of the antihelminthic drug praziquantel.
    Mutapi F; Rujeni N; Bourke C; Mitchell K; Appleby L; Nausch N; Midzi N; Mduluza T
    PLoS Negl Trop Dis; 2011 May; 5(5):e1143. PubMed ID: 21610855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of praziquantel in preschool-aged children in an area co-endemic for Schistosoma mansoni and S. haematobium.
    Coulibaly JT; N'gbesso YK; Knopp S; Keiser J; N'Goran EK; Utzinger J
    PLoS Negl Trop Dis; 2012; 6(12):e1917. PubMed ID: 23236526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of praziquantel syrup (Epiquantel®) against Schistosoma haematobium and Schistosoma mansoni in preschool-aged children in Niger.
    Garba A; Lamine MS; Djibo A; Tahirou A; Aouami MA; Alfari A; Phillips AE; Fenwick A; Utzinger J
    Acta Trop; 2013 Nov; 128(2):318-25. PubMed ID: 23237719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety, efficacy and acceptability of praziquantel in the treatment of Schistosoma haematobium in pre-school children of Kwale County, Kenya.
    Kimani BW; Mbugua AK; Kihara JH; Ng'ang'a M; Njomo DW
    PLoS Negl Trop Dis; 2018 Oct; 12(10):e0006852. PubMed ID: 30332403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamics of Schistosoma haematobium egg output and associated infection parameters following treatment with praziquantel in school-aged children.
    Stete K; Krauth SJ; Coulibaly JT; Knopp S; Hattendorf J; Müller I; Lohourignon LK; Kern WV; N'goran EK; Utzinger J
    Parasit Vectors; 2012 Dec; 5():298. PubMed ID: 23259435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicted impact of mass drug administration on the development of protective immunity against Schistosoma haematobium.
    Mitchell KM; Mutapi F; Mduluza T; Midzi N; Savill NJ; Woolhouse ME
    PLoS Negl Trop Dis; 2014; 8(7):e3059. PubMed ID: 25079601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benefits of annual chemotherapeutic control of schistosomiasis on the development of protective immunity.
    Chisango TJ; Ndlovu B; Vengesai A; Nhidza AF; Sibanda EP; Zhou D; Mutapi F; Mduluza T
    BMC Infect Dis; 2019 Mar; 19(1):219. PubMed ID: 30832614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new rapid diagnostic test for detection of anti-Schistosoma mansoni and anti-Schistosoma haematobium antibodies.
    Coulibaly JT; N'Goran EK; Utzinger J; Doenhoff MJ; Dawson EM
    Parasit Vectors; 2013 Jan; 6():29. PubMed ID: 23360734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of single-dose 40 mg/kg oral praziquantel in the treatment of schistosomiasis in preschool-age versus school-age children: An individual participant data meta-analysis.
    Olliaro PL; Coulibaly JT; Garba A; Halleux C; Keiser J; King CH; Mutapi F; N'Goran EK; Raso G; Scherrer AU; Sousa-Figueiredo JC; Stete K; Utzinger J; Vaillant MT
    PLoS Negl Trop Dis; 2020 Jun; 14(6):e0008277. PubMed ID: 32569275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The current epidemiological status of urogenital schistosomiasis among primary school pupils in Katsina State, Nigeria: An imperative for a scale up of water and sanitation initiative and mass administration of medicines with Praziquantel.
    Atalabi TE; Adoh SD; Eze KM
    PLoS Negl Trop Dis; 2018 Jul; 12(7):e0006636. PubMed ID: 29979684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of circulating cathodic antigen strips for the diagnosis of urinary schistosomiasis.
    Midzi N; Butterworth AE; Mduluza T; Munyati S; Deelder AM; van Dam GJ
    Trans R Soc Trop Med Hyg; 2009 Jan; 103(1):45-51. PubMed ID: 18951599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.